China FDA Highlights Product Recalls, Manufacturers Urged To Make Rapid Responses
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite being one of the largest medical product markets in the world, China has seen few product recalls. The situation could be changing however as China FDA has requested drug and device manufacturers to quickly withdraw products that have deficiencies and potential safety risks.
You may also be interested in...
FDA Inspection Growth In China Stymied By Visa Issues
The agency is waiting for approval to locate 10 new drug inspectors in China.
J&J Consumer Business Picks Up, But Analysts See Long Road
The consumer business inched up 1% operationally in Q3, including about 6% growth at constant currency in OTC/nutritionals. However, costs associated with the remediation of McNeil OTC facilities are expected to weigh on J&J through most of 2013.
China Passes Food Safety Law Following Melamine Infant Formula Disasters
SHANGHAI - China's top legislature passed the long-awaited Food Safety Law in response to a national call for stricter food safety following the Sanlu dairy melamine incident, which led to the deaths of six infants last year (PharmAsia News, Jan. 5, 2009)